BackMBX Biosciences Common Stock Overview

MBX Biosciences Common Stock Total Assets

Track MBX Biosciences Common Stock's total assets ($440M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$435.91M
↑ 88.28% YoYΔ $204.39M vs prior year quarter

Peer trimmed avg / median

Loading

MBX Biosciences Common Stock Total Assets History

Loading

MBX Biosciences Common Stock vs. peers: Total Assets Comparison

Loading

MBX Biosciences Common Stock Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MBX Biosciences Common Stock (MBX) FAQ

As of the most recent data (June 2026), MBX shows a total assets of $440M. That compares with $230M in the prior-year period — up 88.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MBX's total assets is now $440M (was $230M) — a 88.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MBX Biosciences Common Stock is outperforming or lagging.

Tracking MBX's total assets over time shows whether MBX Biosciences Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $440M That compares with $230M in the prior-year period — up 88.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has MBX Biosciences Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $440M) with ownership activity and broader fundamentals.

MBX Biosciences Common Stock's total assets is $440M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.